Cas no 821794-56-3 (1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI))

1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) structure
821794-56-3 structure
Product Name:1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI)
CAS No:821794-56-3
MF:C11H20ClNO6
MW:297.73
CID:696520
PubChem ID:169446573
Update Time:2025-11-02

1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) Chemical and Physical Properties

Names and Identifiers

    • 1-Propanaminium,3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride
    • 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI)
    • Succinyl Carnitine Chloride Salt
    • (2R)-3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-1-propanaminium Inner Salt;
    • 821794-56-3
    • Inchi: 1S/C11H19NO6.ClH/c1-12(2,3)7-8(6-10(15)16)18-11(17)5-4-9(13)14;/h8H,4-7H2,1-3H3,(H-,13,14,15,16);1H
    • InChI Key: BIVQAHUBQIUEBB-UHFFFAOYSA-N
    • SMILES: C(CC(=O)O)(C[N+](C)(C)C)OC(=O)CCC(=O)O.[Cl-]

Computed Properties

  • Exact Mass: 297.0979151g/mol
  • Monoisotopic Mass: 297.0979151g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 7
  • Heavy Atom Count: 19
  • Rotatable Bond Count: 9
  • Complexity: 320
  • Covalently-Bonded Unit Count: 2
  • Defined Atom Stereocenter Count: 1
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 101?2

1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHENG KE LU SI SHENG WU JI SHU
sc-472569-10mg
Succinyl Carnitine Chloride Salt,
821794-56-3
10mg
¥3234.00 2023-09-05

Additional information on 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI)

Recent Advances in the Study of 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) (CAS: 821794-56-3)

In recent years, the compound 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) (CAS: 821794-56-3) has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, known for its unique structural and functional properties, has been the subject of numerous studies aimed at exploring its potential applications in drug development, biomaterial engineering, and therapeutic interventions. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its chemical characteristics, biological activities, and potential industrial applications.

The chemical structure of 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) features a quaternary ammonium group, carboxylate functionalities, and an ester linkage, which collectively contribute to its amphiphilic nature. This structural complexity enables the compound to interact with various biological molecules, including proteins, lipids, and nucleic acids, making it a promising candidate for drug delivery systems and surface modification of biomaterials. Recent studies have demonstrated its efficacy in enhancing the solubility and stability of hydrophobic drugs, thereby improving their bioavailability and therapeutic outcomes.

One of the most notable advancements in the research of this compound is its application in the development of novel drug delivery systems. A study published in the Journal of Controlled Release (2023) investigated the use of 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) as a surfactant in the formulation of nanoemulsions for targeted drug delivery. The results indicated that the compound significantly improved the encapsulation efficiency and release kinetics of anticancer drugs, leading to enhanced tumor suppression in preclinical models. These findings underscore the potential of this compound in overcoming the limitations of conventional drug delivery systems.

In addition to its pharmaceutical applications, recent research has also explored the role of this compound in biomaterial engineering. A study conducted by a team of researchers at MIT (2022) demonstrated that the incorporation of 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) into polymeric matrices enhanced the mechanical properties and biocompatibility of the resulting materials. This innovation holds promise for the development of advanced medical devices, such as biodegradable stents and tissue engineering scaffolds, which require materials with tailored physicochemical properties.

Despite these promising developments, challenges remain in the large-scale synthesis and commercialization of 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI). Current synthetic routes often involve multi-step processes with low yields, necessitating the development of more efficient and sustainable methodologies. Recent efforts in green chemistry have focused on optimizing the synthesis of this compound using catalytic processes and renewable feedstocks, which could pave the way for its broader industrial adoption.

In conclusion, the compound 1-Propanaminium, 3-carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride (9CI) (CAS: 821794-56-3) represents a versatile and promising molecule in the fields of chemical biology and pharmaceutical research. Its unique structural features and multifunctional properties make it a valuable tool for drug delivery, biomaterial engineering, and therapeutic applications. Future research should focus on addressing the synthetic challenges and further elucidating its mechanisms of action to fully unlock its potential in biomedical and industrial settings.

Recommended suppliers
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing jingzhu bio-technology Co., Ltd.
Shanghai Bent Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk